Catalina Pharma is a startup pharmaceutical company that is focused on pharmacological treatment of intraoperative hypothermia
UA Startup Catalina Pharma Offers New Method to Treat Anesthesia-Induced Hypothermia
A Pharmaceutical Cure for Hypothermia?
U of Arizona start-up repurposes failed pain relief treatment to address surgical hypothermia
Amol Patwardhan, MD, PhD
Andrej Romanovsky, MD, PhD
Secretary, Treasurer and Chief Medical Officer
Amol is a practicing anesthesiologist/pain physician and a pharmacologist with years of experience in TRPV1 pharmacology. He is a PI on funded preclinical and clinical studies.
VP and Chief Scientific Officer-Thermoregulation
Andrej’s lab has discovered the mechanisms of the hypether-mic response to TRPV1 antag-onists. Andrej consulted for 6 big pharma TRP programs. He is the Editor-in-Chief of the journal Temperature
VP and Chief Scientific Officer-Pain
Frank is an internationally recognized preeminent pain pharmacologist with over 500 publications who has served as a consultant to dozens of pharmaceutical companies
President and CEO
Bill is a preclinical and clinical pharmacologist, inventor, and entrepreneur who has worked in pain medicine and anesthesia throughout his career and has helped to bring 6 drugs to the market.